PMC:6562565 / 46667-46742 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6562565","sourcedb":"PMC","sourceid":"6562565","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6562565","text":"➣ In combination with durvalumab (anti-PD-L1) and paclitaxel (chemotherapy)","tracks":[]}